Filed June 29, 2020

Serial No. 90025742

Registered Jan. 26, 2021

Registration No. 6,256,450

Class Human biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; wound treatment in the nature of amniotic material prepared in sheet forms or viscous forms; 006; 018; 044; 046; 051; 052

Case Type Trademark